Maria Carla Dominguez, MD

Srikanth Nagalla, M.D., is chief of benign hematology at Miami Cancer Institute. Dr. Nagalla specializes in treating benign (non-cancerous) hematological conditions, including bleeding and clotting disorders, rare blood disorders, high and low platelets, high and low blood counts, bone marrow failure syndromes and myeloproliferative neoplasms. In addition to his extensive experience in benign hematology, Dr. Nagalla has a master’s degree in microbiology and immunology. He has also contributed significant research to the field of platelet biology that could have a lasting impact on how diseases are treated in the future. He has authored numerous peer-reviewed journal articles and book chapters in the field of hematology. Dr. Nagalla joined Miami Cancer Institute from UT Southwestern Medical Center in Dallas, Texas. Throughout his career, he has served in multiple leadership roles. Dr. Nagalla has a strong understanding of the pathophysiology of blood disorders, which is important when developing personalized treatment plans. It allows him to think outside of the box and provide treatment options that are most beneficial to his patients. He believes in educating patients and their caregivers so they can serve as partners and advocates in the treatment process and experience better outcomes. Dr. Nagalla is also passionate about training the next generation of physicians. He has received several awards for his work in teaching medical students and trainees. He serves on multiple national committees for medical education.When he is not treating patients, Dr. Nagalla enjoys spending time with his family, traveling and golfing.

Rupesh Kotecha, M.D., is a radiation oncologist at Miami Cancer Institute. Dr. Kotecha has specialized training and experience in utilizing the latest in radiation therapy treatment techniques to treat cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiosurgery and stereotactic body radiation therapy. He has a specific interest and expertise in the use of stereotactic radiosurgery in the management of brain metastases to help improve both patient outcomes and quality of life.

Eric D. Schroeder, M.D., is a gynecologic oncologist at Miami Cancer Institute. Dr. Schroeder provides comprehensive and compassionate gynecologic cancer care, including robotic and laparoscopic surgery. His areas of focus include the surgical and medical management of ovarian, uterine, endometrial, cervical, vulvar and vaginal cancers. Dr. Schroeder and his colleagues perform thousands of robotic surgeries each year. Actively involved in research at Miami Cancer Institute, Dr. Schroeder enrolls as many eligible patients as possible in clinical trials, which helps inform and improve future treatments for gynecologic cancers. He is passionate about his work as a gynecologic oncologist because it allows him to work closely with his patients throughout each step of the treatment journey, from diagnosis to surgery to medical management. Dr. Schroeder takes a holistic approach to treating cancer, considering both the patient and her family. He formulates treatment plans for each woman’s individual needs. Dr. Schroeder also believes in giving patients and their families as much time as they need to address questions, concerns and treatment options. When he is not treating patients, Dr. Schroeder enjoys fishing, scuba diving and snow skiing with his family.